Genedata

Genedata is an enterprise biopharma software company that transforms drug discovery, development, and manufacturing through automation, advanced analytics, and embedded artificial intelligence. As the first biologics-native technology company, Genedata has spent more than 25 years partnering with leading biopharmaceutical organizations, biotechs, and life science research institutions worldwide to digitalize complex R&D workflows and enable data-driven decision-making across every stage of the drug development lifecycle.

Genedata is part of Danaher, a global life sciences and diagnostics innovator, which connects Genedata to a broad ecosystem of expertise, technologies, and capabilities. Powered by the Danaher Business System and a culture of continuous improvement, Genedata helps customers solve their toughest challenges with greater speed and certainty, making time a competitive advantage and helping unlock the transformative potential of science and technology to improve billions of lives.

The Genedata Biopharma Platform

• A unified, enterprise-grade platform combining a single, structured data model with workflow automation and embedded AI to accelerate and optimize end-to-end biologics discovery and development across multiple modalities.
• Comprises eight unique software solutions for molecule registration, data analytics, and workflow automation that can be deployed independently or together as an integrated system.
• Developed by scientists for scientists, in close collaboration with industry leaders, ensuring deep biopharma domain knowledge is built into every module.
• Supports the full diversity of large-molecule processes and technologies within a single integrated system, as validated by customers such as Pfizer.
• Recognized with the Bio-IT World 2025 Innovative Practices Award for a collaborative project with Genmab to streamline chromatography workflows using Genedata Chromatics, consolidating data from multiple instruments and experiments to enable molecule assessment and lay a foundation for AI/ML.

Core Capabilities

• Automation and AI: Automated workflows and embedded AI turn raw biopharma data into actionable intelligence, accelerating data workflows, increasing scientific productivity, uncovering hidden insights, and enabling scientific breakthroughs.
• Unified Data Model: A single, structured data foundation powers collaboration and innovation across global R&D teams, ensuring consistency and interoperability across all modules and modalities.
• Advanced Analytics: Sophisticated analytical capabilities support data-driven decisions from early discovery through development to the clinic.
• AI-Native Design: The platform is AI-native and rooted in deep biopharma domain knowledge, designed to support end-to-end automation and enable AI/ML applications across the research and development pipeline.

Deployment, Compliance, and Technical Attributes

• Available as an on-premises deployment or as a SaaS solution, offering flexibility to meet diverse organizational requirements.
• Ready-to-use and fast to deploy, minimizing time to value for biopharma organizations.
• Data integrity, traceability, and compliance are built into the platform by design, helping customers meet regulatory requirements and deliver medicines of high quality, safety, and efficacy.
• Open, scalable, and built on modern technology, ensuring the platform remains future-proof as scientific and regulatory landscapes evolve.
• Designed to be user-friendly, making complex workflows and stringent standards intuitive for scientists and operations teams alike.

Customers and Proven Track Record

• Trusted for more than 25 years by leading biopharmaceutical and biotechnology companies as well as cutting-edge life science research institutions worldwide.
• Customers include major global biopharma organizations such as Pfizer and Genmab, among others, who rely on Genedata for full process coverage, data integrity, and global R&D team collaboration.
• Customers consistently report the highest value realization and maximum ROI year-over-year.
• Selected by customers following thorough evaluation processes as the best-in-class antibody and large-molecule workflow platform.

Community, Education, and Events

• Genedata hosts an annual partner symposium and recurring Webinar Week events, bringing together biopharma leaders to share actionable insights, real-world strategies, applied use cases, and guidance on technologies transforming modern R&D.
• Expert-led sessions cover topics including AI agents in scientific research, high-throughput screening technologies, bioprocess unified data foundations, and more.
• The company actively fosters a community of biopharma innovators through networking events, press releases, blog content, and educational resources.

Genedata's mission is to empower biopharma organizations worldwide to innovate boldly, operate efficiently, and accelerate the discovery, development, and manufacturing of next-generation medicines — delivering solutions on time, with compliance built in, and with a commitment to maximizing the scientific and operational impact for every customer.